HULC and adenoma: Herein, we demonstrated that serum CCAT2 and HULC were differentially expressed between CRC patients and controls and/or adenoma patients, and discriminated CRC from other groups with moderate sensitivity and specificity, suggesting serum HULC and CCAT2 as novel potential early biomarkers for CRC diagnosis.